Page last updated: 2024-11-06

ribose-5-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ribose-5-phosphate (R5P) is a key intermediate in the pentose phosphate pathway (PPP), a metabolic route that diverges from glycolysis. It is synthesized from glucose-6-phosphate through a series of enzymatic reactions, specifically via the oxidative phase of the PPP. R5P plays a critical role in nucleotide biosynthesis, serving as a precursor for the synthesis of purine and pyrimidine bases, which are essential components of DNA and RNA. It also contributes to NADPH production, which is essential for reducing oxidative stress and supporting biosynthesis processes. The PPP and its associated R5P production are crucial for cell growth and proliferation, particularly in rapidly dividing cells. R5P is also involved in the synthesis of other essential biomolecules, such as coenzymes like NAD and FAD. Extensive research on R5P focuses on its role in metabolism, its potential therapeutic implications in conditions related to nucleotide metabolism and oxidative stress, and its involvement in cell signaling pathways.'

ribose-5-phosphate: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID77982
CHEBI ID17797
SCHEMBL ID21609
MeSH IDM0099209

Synonyms (35)

Synonym
unii-4b2428flto
4b2428flto ,
einecs 224-310-2
R52 ,
5-o-phosphono-d-ribose
d-ribose 5-(dihydrogen phosphate)
CHEBI:17797
ribose-5-phosphate
r-5-p
ribose, 5-(dihydrogen phosphate), d-
d-ribose-5-phosphate
ribose 5-monophosphate
ribose phosphate
d-ribose-5-phosphoric acid
4300-28-1
ribose 5-phosphate
DB02053
ABB1E31D-D9D5-495C-87E6-30B76950F976
BMSE000278
[(2r,3r,4r)-2,3,4-trihydroxy-5-oxopentyl] dihydrogen phosphate
ribose, 5-(dihydrogen phosphate)
3615-55-2
SCHEMBL21609
ribose 5-phosphate, d-
d-ribose-5-phosphoric acid [mi]
d-ribose, 5-(dihydrogen phosphate)-
PPQRONHOSHZGFQ-LMVFSUKVSA-N
DTXSID10897600
Q418855
rel-(2r,3r,4r)-2,3,4-trihydroxy-5-oxopentyl dihydrogen phosphate
(rel)-d-ribose 5-phosphate
(2r,3r,4r)-2,3,4-trihydroxy-5-oxopentyl dihydrogen phosphate
HY-W009371A
CS-0114968
AKOS040744213

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" It is concluded that Rib5P, generated in the oxidative segment of the PPP, is an important determinant of PPRibP synthesis in the lactating rat mammary gland and that insulin plays a central role in the regulation of the bioavailability of this precursor of nucleotide and nucleic acid synthesis."( Phosphoribosyl pyrophosphate and phosphoribosyl pyrophosphate synthetase in rat mammary gland. Changes in the lactation cycle and effects of diabetes, insulin and phenazine methosulphate.
Greenbaum, AL; Kunjara, S; McLean, P; Salih, N; Sochor, M, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
D-ribose 5-phosphateA ribose monophosphate that is D-ribose substituted at position 5 by a phosphate group. It is an intermediate in the pentose phosphate pathway.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics2719
Metabolic reprogramming in pancreatic cancer4223
Calvin cycle319

Research

Studies (228)

TimeframeStudies, This Drug (%)All Drugs %
pre-199085 (37.28)18.7374
1990's27 (11.84)18.2507
2000's56 (24.56)29.6817
2010's50 (21.93)24.3611
2020's10 (4.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 71.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index71.26 (24.57)
Research Supply Index5.48 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index121.77 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (71.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.42%)5.53%
Reviews8 (3.38%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other228 (96.20%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]